Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

World Health Forum: New Genzyme CEO warns on perils of scale
Bizjournals.com
Thursday, October 27, 2011 - 4:09pm
tags:
Genzyme, David Meeker, Sanofi
FDA says Yaz and other new birth control drugs appear to increase blood clot risk
Yahoo/AP
Thursday, October 27, 2011 - 4:07pm
tags:
FDA, birth control pill, Yaz, Bayer
10 Promising Therapeutic Vaccines
Fierce Vaccines
Thursday, October 27, 2011 - 1:40pm
tags:
vaccines, ICT-107, glioblastoma, ImmunoCellular, VGX-3100, Inovio, cervical cancer, MAGE-A3, GSK, skin cancer, lung cancer, NeuVax, breast cancer, RXi Pharmaceuticals, Antigen Express, AE37, Nexvax2, celiac disease, ImmusanT, ADXS-HPV, head and neck cancer, Advaxis, GI-4000, GlobeImmune, pancreatic cancer, PEV7, Pevion Biotech
Swiss activists plan 'occupy' protest at Novartis chair's house
Fierce Pharma
Thursday, October 27, 2011 - 1:31pm
tags:
Novartis, Daniel Vasella, activists
Pfizer Inc. Third Quarter Earnings on the Horizon
Yahoo/Wall St. Cheat Sheet
Thursday, October 27, 2011 - 1:29pm
tags:
Pfizer, earnings
Bayer Third-Quarter Profit More Than Doubles on Demand in Emerging Markets
Bloomberg
Thursday, October 27, 2011 - 11:44am
tags:
Bayer AG, earnings
Elan Posts Profit on Tysabri Gains, Sale of Technology Unit
Bloomberg
Thursday, October 27, 2011 - 11:40am
tags:
Elan, earnings, Tysabri
Novo Nordisk Q3 net profit rises 17 percent
Yahoo/AP
Thursday, October 27, 2011 - 11:34am
tags:
Novo Nordisk, earnings
Cubist's Adolor Acquisition Aligns Well With Its Own Skill Set
Seeking Alpha
Thursday, October 27, 2011 - 11:33am
tags:
Adolor, Cubist, M&A
Dr. Reddy's Continues to Grow
Yahoo/Zacks.com
Thursday, October 27, 2011 - 11:32am
tags:
Dr Reddy's, earnings
New job opportunities emerging in Big Pharma
Fierce Pharma
Thursday, October 27, 2011 - 11:20am
tags:
layoffs
Doctors Are Split On Avastin For Breast Cancer
Pharmalot
Thursday, October 27, 2011 - 11:12am
tags:
breast cancer, physicians, Avastin, Roche, Taxol
Gardasil Policy May Grow Coverage Without Reversing Sales Slide
Bloomberg Businessweek
Thursday, October 27, 2011 - 11:11am
tags:
HPV, Merck, Gardasil
Eli Lilly Is Overvalued, Pfizer More Attractive
Seeking Alpha
Thursday, October 27, 2011 - 11:07am
tags:
Eli Lilly, Pfizer, Sanofi, GSK
Pfizer's blockbuster pneumonia vaccine Prevnar 13 gets EU approval for adults 50 and older
Yahoo/AP
Thursday, October 27, 2011 - 11:06am
tags:
Pfizer, Prevnar 13, vaccine, Europe, pneumonia
AstraZeneca Q3 net profit boosted by disposal
Yahoo/AP
Thursday, October 27, 2011 - 9:29am
tags:
earnings, AstraZeneca
Bristol-Myers Tops Third-Quarter Profit Estimate
Bloomberg
Thursday, October 27, 2011 - 8:20am
tags:
earnings, Bristol-Myers Squibb
Another Round Of Milestone News Solidifies Ampio's Pipeline Potential
Seeking Alpha
Wednesday, October 26, 2011 - 6:14pm
tags:
Ampio Pharmaceuticals, Ampion, Daewoong Pharmaceuticals, Optina, diabetic macular edema, Zertane, premature ejaculation, osteoarthritis
Earnings Preview: Merck reports on third quarter
Yahoo/AP
Wednesday, October 26, 2011 - 6:12pm
tags:
earnings, Merck
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bloomberg
Wednesday, October 26, 2011 - 6:12pm
tags:
Bristol-Myers Squibb, diabetes, FDA, AstraZeneca, Dapagliflozin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.